Celgene wins approval for drug key to Bristol buyout

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 16, 2019 at 1:22 PM.

  1. #1 cafead, Aug 16, 2019 at 1:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Celgene on Friday won U.S. approval for Inrebic, a treatment for myelofibrosis that is one of five drugs Bristol-Myers Squibb regarded as particularly valuable in its $74 billion deal to buy Celgene.

    article source
     
    Quote

Reply to Thread